Changes in programmed death ligand 1 expression in non-small cell lung cancer patients who received...
Changes in programmed death ligand 1 expression in non-small cell lung cancer patients who received anticancer treatments
About this item
Full title
Author / Creator
Omori, Shota , Kenmotsu, Hirotsugu , Abe, Masato , Watanabe, Reiko , Sugino, Takashi , Kobayashi, Haruki , Nakashima, Kazuhisa , Wakuda, Kazushige , Ono, Akira , Taira, Tetsuhiko , Naito, Tateaki , Murakami, Haruyasu , Ohde, Yasuhisa , Endo, Masahiro , Akiyama, Yasuto , Nakajima, Takashi and Takahashi, Toshiaki
Publisher
Tokyo: Springer Japan
Journal title
Language
English
Formats
Publication information
Publisher
Tokyo: Springer Japan
Subjects
More information
Scope and Contents
Contents
Background
The expression of programmed death ligand 1 (PD-L1) is considered a predictive biomarker of anti-programmed death 1 (PD-1)/PD-L1 cancer therapies. However, changes in PD-L1 expression of tumor cells during clinical courses have not been fully evaluated. We evaluated changes in PD-L1 expression for non-small cell lung cancer (NSCLC) pa...
Alternative Titles
Full title
Changes in programmed death ligand 1 expression in non-small cell lung cancer patients who received anticancer treatments
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2060866584
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2060866584
Other Identifiers
ISSN
1341-9625
E-ISSN
1437-7772
DOI
10.1007/s10147-018-1305-4
